Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Cohen

Showing results (181-190 of 298) with videos related to

Pageof 30
Sort By:
Archives of Cardiovascular Diseases|November 13, 2016
Non-vitamin K antagonist oral anticoagulants and heart failureRichard Isnard, Fabrice Bauer, Alain Cohen-Solal, et al.
JAMA Internal Medicine|October 16, 2013
An education program for risk factor management after an acute coronary syndrome: a randomized clinical trialAriel Cohen, Patrick Assyag, Louise Boyer-Chatenet, et al.
International Journal of Cardiology|December 29, 2009
Circulating procoagulant microparticles in acute pulmonary embolism: a case-control studyLaurence Bal, Stéphane Ederhy, Emanuele Di Angelantonio, et al.
Critical Reviews in Oncology/Hematology|February 19, 2011
Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologistsStephane Ederhy, Hassan Izzedine, Christophe Massard, et al.
Archives of Cardiovascular Diseases|April 25, 2018
Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation?Yann Ancedy, Emmanuelle Berthelot, Sylvie Lang, et al.
Annals of Intensive Care|September 19, 2023
In-hospital outcomes after acute myocardial infarction with obstructive coronary artery disease in critically ill patients hospitalized for non-cardiac diseaseMorgan Roué, Alexis F Guédon, Nathanaël Lapidus, et al.
Archives of Cardiovascular Diseases|November 14, 2020
Left ventricular ejection fraction: An additional risk marker in COVID-19Laurie Soulat-Dufour, Sylvie Lang, Stephane Ederhy, et al.
Frontiers in Cardiovascular Medicine|April 18, 2022
Inverted Takotsubo Syndrome With HELLP Syndrome: A Case ReportPaul Gabarre, Pablo Ruiz, Camille Chenevier-Gobeaux, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 10, 2020
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trialMonika Kozieł, Naab Al-Saady, Søren P Hjortshøj, et al.
American Heart Journal|December 17, 2016
Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudyFranck Boccara, Joe Miantezila Basilua, Murielle Mary-Krause, et al.
Pageof 30

Showing results (181-190 of 298) with videos related to

Sort By:
Pageof 30
Archives of Cardiovascular Diseases|November 13, 2016
Non-vitamin K antagonist oral anticoagulants and heart failureRichard Isnard, Fabrice Bauer, Alain Cohen-Solal, et al.
JAMA Internal Medicine|October 16, 2013
An education program for risk factor management after an acute coronary syndrome: a randomized clinical trialAriel Cohen, Patrick Assyag, Louise Boyer-Chatenet, et al.
International Journal of Cardiology|December 29, 2009
Circulating procoagulant microparticles in acute pulmonary embolism: a case-control studyLaurence Bal, Stéphane Ederhy, Emanuele Di Angelantonio, et al.
Critical Reviews in Oncology/Hematology|February 19, 2011
Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologistsStephane Ederhy, Hassan Izzedine, Christophe Massard, et al.
Archives of Cardiovascular Diseases|April 25, 2018
Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation?Yann Ancedy, Emmanuelle Berthelot, Sylvie Lang, et al.
Annals of Intensive Care|September 19, 2023
In-hospital outcomes after acute myocardial infarction with obstructive coronary artery disease in critically ill patients hospitalized for non-cardiac diseaseMorgan Roué, Alexis F Guédon, Nathanaël Lapidus, et al.
Archives of Cardiovascular Diseases|November 14, 2020
Left ventricular ejection fraction: An additional risk marker in COVID-19Laurie Soulat-Dufour, Sylvie Lang, Stephane Ederhy, et al.
Frontiers in Cardiovascular Medicine|April 18, 2022
Inverted Takotsubo Syndrome With HELLP Syndrome: A Case ReportPaul Gabarre, Pablo Ruiz, Camille Chenevier-Gobeaux, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 10, 2020
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trialMonika Kozieł, Naab Al-Saady, Søren P Hjortshøj, et al.
American Heart Journal|December 17, 2016
Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudyFranck Boccara, Joe Miantezila Basilua, Murielle Mary-Krause, et al.
Pageof 30